Palmitoleic Acid Inhibits RANKL-Induced Osteoclastogenesis and Bone Resorption by Suppressing NF-κB and MAPK Signalling Pathways

類似資料

• Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB
  著者:: Quan, Gui-Hua, 等
  出版事項: (2015)
• Galangin suppresses RANKL‐induced osteoclastogenesis via inhibiting MAPK and NF‐κB signalling pathways
  著者:: Li, Xiucheng, 等
  出版事項: (2021)
• Niloticin inhibits osteoclastogenesis by blocking RANKL–RANK interaction and suppressing the AKT, MAPK, and NF-κB signaling pathways
  著者:: Huanhuan Xu, 等
  出版事項: (2022-05-01)
• Aspirin inhibits osteoclastogenesis by suppressing the activation of NF-κB and MAPKs in RANKL-induced RAW264.7 cells
  著者:: Zeng, Yan-Ping, 等
  出版事項: (2016)
• A novel BRD4 inhibitor suppresses osteoclastogenesis and ovariectomized osteoporosis by blocking RANKL-mediated MAPK and NF-κB pathways
  著者:: Liu, Ying, 等
  出版事項: (2021)